Evidence map›Paper›PMID 41561536›Full record

ArticleEcancermedicalscience2025

Long-term outcomes with non-dose dense chemotherapy for Ewing sarcoma - a follow up of the cohort treated with EFT-2001 protocol.

Badira Cheriyalinkal Parambil, Girish Chinnaswamy, Maya Prasad, Venkata Rama Mohan Gollamudi, Ajay Puri, Ashish Gulia, Sajid Qureshi, Prakash Nayak, Manish Pruthi, Siddhartha Laskar and 10 more

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Badira Cheriyalinkal ParambilDepartment of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Girish ChinnaswamyDepartment of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Maya PrasadDepartment of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Venkata Rama Mohan GollamudiDepartment of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Ajay PuriDepartment of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Ashish GuliaDepartment of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Sajid QureshiDepartment of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Prakash NayakDepartment of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Manish PruthiDepartment of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Siddhartha LaskarDepartment of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Nehal KhannaDepartment of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Jifmi Jose ManjaliDepartment of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Amit JanuDepartment of Radiodiagnosis, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Sneha ShahDepartment of Nuclear Medicine, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Nilendu PurandareDepartment of Nuclear Medicine, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Mukta RamadwarDepartment of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Poonam PanjwaniDepartment of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Bharat RekhiDepartment of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Pallavi RaneClinical Research Secretariat, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.
Shripad BanavaliDepartment of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai 400094, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Collaborative trials of co-operative groups have currently established interval compressed chemotherapy (ICC) as the standard of care, though there are concerns regarding the application of the same in low middle-income countries (LMICs). This study is a retrospective analysis of the long-term outcomes of a follow-up cohort (

Indexed as

cardiotoxicityEwing sarcomalong-term outcomesnon-dose dense chemotherapy

Identifiers

PMID41561536
PMCPMC12812818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.